natgillin/translations-raw huggingface dataset:
A method of making a container having a bottom and a peripheral side wall extending from said bottom and defining opposite said bottom a peripheral rim, said side wall having connecting means for attaching said plastic lid to said container in a tight relationship, said lid and said side wall tightly abutting each other in a peripheral sealing area adjacent said rim when said lid is attached to said container, characterised in the lid and the side wall (46) having on the surfaces thereof facing the inside of the packaging a number of projections, said projections (8) on said side wall defining a number of side wall recesses (9) and being integrally formed in the injection moulding process by the plastic material forming the container side wall flowing into mould recesses (9) formed in said injection mould. 
Postupak izrade spremnika s dnom i perifernim zidom koji se pruža od navedenog dna i definira periferni rub nasuprot navedenom dnu, navedeni bočni zid ima povezujuća sredstva za tijesno pričvršćivanje plastičnog poklopca na navedeni spremnik, navedeni poklopac i navedeni bočni zid tijesno se dodiruju u perifernom području pričvršćivanja u dodiru s navedenim rubom kada je navedeni poklopac pričvršćen na navedeni spremnik, pri čemu bočni zid (46) na unutarnjem dijelu površine spremnika ima niz projekcija, navedene projekcije (8) na navedenom bočnom zidu određuju niz udubljenja (9) te su integralno formirane u postupku injekcijskog oblikovanja plastičnim materijalom koji formira bočni zid spremnika koji ulazi u udubljenja kalupa (9) formirana u navedenom injekcijskom kalupu, tako da barem područje, po mogućnosti čitavo područje navedenih površina sučelice unutrašnjosti spremnika ima stupanj grubosti 3D Ra veći od 15 µm i
A capsule (2) according to any one of the preceding claims, wherein a ridge of the plurality of ridges (28.i) has a height that is equal to or less than a thickness of the flange-like rim (20). 
Sistem prema bilo kojem od patentnih zahtjeva 2-6, naznačen time da ispust (28.i) koji se sastoji od mnoštva ispusta (28.i) ima visinu koja je jednaka ili manja od debljine (HF) ruba (20) u obliku prirubnice.
A capsule (2) according to any one of the preceding claims, wherein the thickness of the flange-like rim (20) is greater at the location where the ridges (28.i) are present than at a location adjacent thereto. 
Sistem prema bilo kojem od patentnih zahtjeva 2-7, naznačen time da je debljina (HF) ruba (20) u obliku prirubnice veća na mjestu gdje se nalaze ispusti (28.i) nego na njemu susjednom mjestu.
A capsule (2) according to any one claims 1-7, wherein the thickness of the flange-like rim (20) is smaller at the location where the ridges (28.i) are present than at a location adjacent thereto. 
Sistem prema bilo kojem od patentnih zahtjeva 2-7, naznačen time da je debljina (HF) ruba (20) u obliku prirubnice manja na mjestu gdje se nalaze ispusti (28.i) nego na njemu susjednom mjestu.
A capsule (2) according to any one of the preceding claims, wherein a ridge of the plurality of ridges (28.i) has a maximum width of less than 0.3 mm, preferably less than 0.21 mm, more preferably less than 0.15 mm. 
Sistem prema bilo kojem od patentnih zahtjeva 2-13, naznačen time da ispust (28.i) koji se sastoji od mnoštva ispusta (28.i) ima maksimalnu širinu manju od 0.3 mm, poželjnije manju od 0.21 mm, još poželjnije manju od 0.15 mm.
A capsule (2) according to any one of the preceding claims, wherein the ridges (28.i) are made from a plastics material. 
Sistem prema bilo kojem od patentnih zahtjeva 2-14, naznačen time da su ispusti (28.i) napravljeni od plastičnih materijala.
Fitting system according to claim 1, said first angle of conicity (β1) being comprised between 1° and 2° and preferably being about 1.5°. 
Element cijevi sukladno Zahtjevu 1, navedeni prvi kut koničnosti (β1) sadržan je između 1° i 2° te po mogućnosti otprilike 1.5°.
System according to any one of the previous claims, wherein the male end (11) comprises a depression or throat (3) that substantially separates from one another said two portions (4, 2) of the male end having different angles of conicity. 
Element cijevi sukladno bilo kojem od ranijih Zahtjeva, pri čemu muški kraj (11) sadrži udubljenje ili grlo (3) koje u biti međusobno razdvaja navedena dva dijela (4,2) muškog kraja koji imaju različite kuteve koničnosti.
System according to claim 4, wherein said depression or throat (3) has a diameter, at the throat section, that is smaller than the diameter of the adjoining conical portions (2, 4). 
Element cijevi sukladno Zahtjevu 4, pri čemu navedeno udubljenje ili grlo (3), na dijelu grla, ima promjer manji od susjednih koničnih dijelova (2,4).
System according to claim 6, said female end having two ribbings (5, 6), which form a double ribbing with an intermediate region (23) between the two ribbings, for receiving a locking means like a flange or a strap. 
Element cijevi sukladno Zahtjevu 6, navedeni ženski kraj ima dva rebrasta ojačanja (5,6) koji formiraju dvostruko rebrasto ojačanje s međuregijom (23) između dva ojačanja, za prihvat sredstva za zabravljivanje poput prirubnice ili remena.
Element for modular pipes according to claim 9, made from metal sheet of small thickness. 
Element cijevi sukladno Zahtjevu 9, načinjen od metalnog lima male debljine.
Set of elements for making modular pipes, particularly for making chimney flues and the like, comprising pipe elements (10, 20) with a conical fitting according to any one of the previous claims. 
Sustav elemenata za izradu modularnih cijevi, osobito za izradu vodova dimnjaka i slično, sadrži elemente cijevi (10, 20) sukladno bilo kojem od Zahtjeva 1 do 11.
A method according to claim 23, wherein each ridge (28.i) of the plurality of ridges (28.i) has substantially the same height (HR). 
Postupak prema patentnom zahtjevu 23, naznačen time da svaki ispust (28.i) koji se sastoji od mnoštva ispusta (28.i) ima pretežno istu visinu (HR) .
A method according to any one of claims 23-34, wherein a ridge (28.i) of the plurality of ridges (28.i) has a maximum width of less than 0.3 mm, preferably less than 0.21 mm, more preferably less than 0.15 mm. 
Postupak prema bilo kojem od patentnih zahtjeva 23-34, naznačen time da ispust (28.i) koji se sastoji od mnoštva ispusta (28.i) ima maksimalnu širinu manju od 0,3 mm, poželjno manju od 0,21 mm, a još poželjnije i manju od 0,15 mm.
at least an area, and preferably the entire area, of said surfaces of the peripheral side wall facing the inside of the packaging has a 3D roughness Ra of at most 70µm. 
barem područje, a po mogućnosti čitavo područje navedene površine perifernog bočnog zida sučelice unutarnjeg dijela pakiranja ima stupanj grubosti 3D Ra od najviše 70 µm.
A packaging according to claim 1, characterized in that at least an area, and preferably the entire area, of said surfaces facing the inside of the packaging having a 3D roughness Ra of at minimum 40µm and at most 70µm. 
Pakiranje sukladno Zahtjevu 1, naznačeno time da barem područje, po mogućnosti čitavo područje navedenih površina koje su sučelice unutarnjem dijelu pakiranja Ra od minimum 40 µm te najviše 70 µm.
A packaging according to any one of the preceding claims, said recesses (9) all having essentially the same depth (R), or the same depth. 
Pakiranje sukladno bilo kojem od prethodnih Zahtjeva, navedena udubljenja (9) sva u osnovi iste dubine (R), ili iste dubine.
A mould according to claim 12, said first surface (110) having a 3D roughness Ra greater than 20µm, more preferably greater than 40µm and most preferably greater than 53µm, for defining said projections (8). 
Kalup sukladno Zahtjevu 12, navedena prva površina (110) ima stupanj grubosti 3D Ra veći od 20 µm, po mogućnosti veći od 40 µm, a najbolje veći od 53 µm, za definiranje navedenih projekcija (8).
A mould according to any of claims 12-14, said first surface (110) having a 3D roughness Ra of at minimum 40µm and at most 70µm. 
Kalup sukladno bilo kojem od Zahtjeva 12-14, navedena prva površina (110) ima stupanj grubosti 3D Ra minimalno 40 µm te najviše 70 µm.
A mould according to claim 12, said indentations (9) all having the same depth, or essentially the same depth. 
Kalup sukladno Zahtjevu 12, navedena udubljenja (9) sva su iste dubine, ili u osnovi iste dubine.
A method of making a container having a bottom and a peripheral side wall extending from said bottom and defining opposite said bottom a peripheral rim, said side wall having connecting means for attaching a plastic lid to said container in a tight relationship, said lid and said side wall tightly abutting each other in a peripheral sealing area adjacent said rim when said lid is attached to said container, wherein the side wall (46) has on the surfaces thereof facing the inside of the container a number of projections, said projections (8) on said side wall defining a number of side wall recesses (9) and being integrally formed in the injection moulding process by the plastic material forming the container side wall flowing into mould recesses (9) formed in said injection mould, such that at least an area, and preferably the entire area, of said surfaces facing the inside of the container having a 3D roughness Ra greater than about 15 µm and 
Postupak izrade spremnika s dnom i perifernim zidom koji se pruža od navedenog dna i definira periferni rub nasuprot navedenom dnu, navedeni bočni zid ima povezujuća sredstva za tijesno pričvršćivanje plastičnog poklopca na navedeni spremnik, navedeni poklopac i navedeni bočni zid tijesno se dodiruju u perifernom području pričvršćivanja u dodiru s navedenim rubom kada je navedeni poklopac pričvršćen na navedeni spremnik, pri čemu bočni zid (46) na unutarnjem dijelu površine spremnika ima niz projekcija, navedene projekcije (8) na navedenom bočnom zidu određuju niz udubljenja (9) te su integralno formirane u postupku injekcijskog oblikovanja plastičnim materijalom koji formira bočni zid spremnika koji ulazi u udubljenja kalupa (9) formirana u navedenom injekcijskom kalupu, tako da barem područje, po mogućnosti čitavo područje navedenih površina sučelice unutrašnjosti spremnika ima stupanj grubosti 3D Ra veći od 15 µm i
said side wall (46) recesses (9) have a depth (R) of 0.1 mm-0.35mm or 
Navedene udubine na bočnom zidu (46) imaju dubinu (R) od 0.1 mm-0.35mm ili
at least an area, and preferably the entire area, of said surfaces facing the inside of the container having a 3D roughness Ra of at most 70 µm. 
Barem područje, a po mogućnosti čitavo područje navedenih površina sučelice unutrašnjosti spremnika ima stupanj grubosti 3D Ra od najviše 70 µm.
The composition according to claim 1, which comprises the ingredient (a) of 0.5 to 30% by weight and the ingredient (b) of 70 to 99.5% by weight. 
Sastav prema zahtjevu 1, naznačen time, da obuhvaća sastojak (a) od 0,5 do 30 masenih % i sastojak (b) od 70 do 99,5 masenih %.
The composition according to claim 1, wherein the ingredient (b) is prepared by calcinating clay at a temperature of 900 to 1300°C. 
Sastav prema zahtjevu 1, naznačen time, da se sastojak (b) pripravlja pomoću kalcinacije gline na temperaturi od 900 do 1300 °C.
The composition according to claim 3, wherein the clay is calcined for 15 minutes to 2 hours. 
Sastav prema zahtjevu 3, naznačen time, da se glina kalcinira u vremenu od 15 minuta do 2 sata.
The composition according to claim 1, wherein the ingredient (b) has a water content of 1 % by weight or less. 
Sastav prema zahtjevu 1, naznačen time, da sastojak (b) ima sadržaj vode od jednog masenog % ili manje od toga.
The composition according to claim 1, wherein the ingredient (a) is (RS)-S-sec-butyl O -ethyl 2-oxo-1,3-thiazolidin-3-ylphosphonothioate. 
Sastav prema zahtjevu 1, naznačen time, da sastojak (a) je (RS)-S-sek-butil-O-etil-2-okso-1,3-tiazolidin-3-ilfosfonotioat.
A process for producing a granulated agricultural composition comprising (RS)- S -sec-butyl O -ethyl 2-oxo-1,3-thiazolidin-3-ylphosphonothioate or O- ethyl S -propyl (E)-[2-(cyanoimino)-3-ethylimidazolidin-1-yl]phosphonothioate as an active ingredient, which comprises compounding calcined clay which is prepared by calcinating clay at a temperature of 800°C or higher to improve stability of the active ingredient. 
Postupak za proizvodnju granuliranog poljoprivrednog sastava koji obuhvaća (RS)-S-sek-butil-O-etil-2-okso-1,3-tiazolidin-3-ilfosfonotioat ili O-etil-S-propil-(E)-[2-(cijanoimino)-3-etilimidazolidin-1-il]fosfonotioat kao djelotvorni sastojak, naznačen time, da obuhvaća primiješanje kalcinirane gline koja se pripravlja pomoću kalcinacije gline na temperaturi od 800°C ili višoj od toga, u svrhu poboljšavanja stabilnosti djelotvornog sastojka.
A method for improving stability of an active ingredient, comprising compounding calcined clay which is prepared by calcinating clay at a temperature of 800°C or higher, wherein the active ingredient is (RS)- S -sec-butyl O -ethyl 2-oxo-1,3-thiazolidin-3-ylphosphonothioate or O -ethyl S -propyl (E)-[2-(cyanoimino)-3-ethylimidazolidin-1-yl]phosphonothioate and is comprised in a granulated agricultural composition. 
Postupak za poboljšavanje stabilnosti djelotvornog sastojka, naznačen time, da obuhvaća primiješanje kalcinirane gline koja se pripravlja pomoću kalcinacije gline na temperaturi od 800°C ili višoj od toga, pri čemu djelotvorni sastojak je (RS)-S-sek-butil-O-etil-2-okso-1,3-tiazolidin-3-ilfosfonotioat ili O-etil-S-propil-(E)-[2-(cijanoimino)-3-etilimidazolidin-1-il]fosfonotioat, i koji se sastavlja u granulirani poljoprivredni sastav.
Pipe element according to claim 1, said first angle of conicity (β1) being comprised between 1° and 2° and preferably being about 1.5°. 
Element cijevi sukladno Zahtjevu 1, navedeni prvi kut koničnosti (β1) sadržan je između 1° i 2° te po mogućnosti otprilike 1.5°.
Pipe element according to any one of the previous claims, wherein the male end (11) comprises a depression or throat (3) that substantially separates from one another said two portions (4, 2) of the male end having different angles of conicity. 
Element cijevi sukladno bilo kojem od ranijih Zahtjeva, pri čemu muški kraj (11) sadrži udubljenje ili grlo (3) koje u biti međusobno razdvaja navedena dva dijela (4,2) muškog kraja koji imaju različite kuteve koničnosti.
Pipe element according to claim 4, wherein said depression or throat (3) has a diameter, at the throat section, that is smaller than the diameter of the adjoining conical portions (2, 4). 
Element cijevi sukladno Zahtjevu 4, pri čemu navedeno udubljenje ili grlo (3), na dijelu grla, ima promjer manji od susjednih koničnih dijelova (2,4).
Pipe element according to claim 6, said female end having two ribbings (5, 6), which form a double ribbing with an intermediate region (23) between the two ribbings, for receiving a locking means like a flange or a strap. 
Element cijevi sukladno Zahtjevu 6, navedeni ženski kraj ima dva rebrasta ojačanja (5,6) koji formiraju dvostruko rebrasto ojačanje s međuregijom (23) između dva ojačanja, za prihvat sredstva za zabravljivanje poput prirubnice ili remena.
Pipe element according to claim 9, made from metal sheet of small thickness. 
Element cijevi sukladno Zahtjevu 9, načinjen od metalnog lima male debljine.
Set of elements for making modular pipes, particularly for making chimney flues and the like, comprising pipe elements (10, 20) according to any one of claims 1 to 11. 
Sustav elemenata za izradu modularnih cijevi, osobito za izradu vodova dimnjaka i slično, sadrži elemente cijevi (10, 20) sukladno bilo kojem od Zahtjeva 1 do 11.
The dog kennel (10) according to claim 3, characterised in that said auxiliary door (20) is movable by translation or by removal and reinsertion. 
Pseća kućica (10) u skladu s patentnim zahtjevom 3, naznačena time da su navedena pomoćna vrata (20) pokretna pomicanjem ili uklanjanjem i ponovnim umetanjem.
The dog kennel (10) according to any one of claims from 2 to 4, characterised in that said support feet (18) are an integral part of the wall/platform, so that the platform is perfectly aligned with the inner floor (11) of the kennel, thereby avoiding the presence of steps. 
Pseća kućica (10) u skladu s bilo kojim od patentnih zahtjeva od 2 do 4, naznačena time što su navedene poduporne noge (18) sastavni dio stijenke / platforme, tako da je platforma savršeno usklađena s unutarnjim dnom (11) kućice, čime se izbjegava prisutnost stepenice.
The dog kennel (10) according to claim 2, characterised in that said support feet (18) fold away and are integrated in the wall and rotate from the inside towards the outside by means of hinges, or are fully cut from the wall, preferably the inner part. 
Pseća kućica (10) prema zahtjevu 2, naznačena time da se navedene poduporne noge (18) preklapaju i integrirane su u stijenki i pomoću šarki rotiraju iznutra prema van, ili su u potpunosti izrezatne iz stijenke, poželjno od unutarnjeg dijela.
The dog kennel (10) according to any one of the preceding claims, characterised in that it is provided with a plurality of pivotable walls, with a first wall being positioned as a platform and another forming an extension of the roof, hooking on to the existing roof to extend over the platform and also to protect it. 
Pseća kućica (10) u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačena time da je predviđeno više zakretnih stijenki, gdje je prva stijenka postavljena kao platforma, a druga tvori proširenje krova gdje se zakači na postojeći krov kako bi se proširila preko platforme i kako bi ju zaštitila.
Providing a porous spray-frozen powder having a particle porosity of at least 35%, an ice crystal pore volume of less than 2.5mL/g, and an ice crystal pore size of less than 3 micrometres; 
osiguravanja poroznog praha smrznutog raspršivanjem s poroznošću čestica od najmanje 35%, volumenom pora ledenih kristala manjim od 2,5 ml/g, te veličinom pora ledenih kristala manjom od 3 µm;
Sintering a layer of the porous spray frozen powder at a temperature below 0°C while gas is forced through the layer, to form a sintered cake 
sinteriranja sloja poroznog praha smrznutog raspršivanjem na temperaturi ispod 0 °C uz protiskivanje plina kroz sloj, kako bi se dobilo sinterirani kolač;
Method according to claim 1, wherein the instant coffee product is grinded after sintering to produce an instant beverage powder. 
Postupak u skladu s patentnim zahtjevom 1, naznačen time što se instant kavu kao proizvod melje nakon sinteriranja kako bi se proizvelo instant napitak u prahu.
Method according to claim 5 wherein the porous spray-frozen powder comprises gas under a pressure of at least 2 bars. 
Postupak u skladu s patentnim zahtjevom 5, naznačen time što porozni prah smrznut raspršivanjem sadrži plin pod tlakom od najmanje 2 bara (200 kPa).
Method according to claim 5 wherein the porous spray-frozen powder comprises at least 1 ml enclosed gas per g of powder. 
Postupak u skladu s patentnim zahtjevom 5, naznačen time što porozni prah smrznut raspršivanjem sadrži najmanje 1 ml uklopljenog plina po g praha.
Method according to any of the preceding claims, wherein the porous spray-frozen powder is maintained at a temperature of below 0°C prior to sintering. 
Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se porozni prah smrznut raspršivanjem drži na temperaturi ispod 0 °C prije sinteriranja.
Method according to any of the preceding claims, wherein the moisture content of the instant beverage product after freeze-drying is 0.5-5%. 
Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što je sadržaj vlage u instant napitku kao proizvodu nakon sušenja smrzavanjem 0,5-5%.
A compound for use in treating or preventing a disease selected from psoriasis, atopic dermatitis, psoriatic arthritis, arthritis, rheumatoid arthritis, an inflammatory bowel disease, multiple sclerosis, a neurodegenerative disorder, congestive heart failure, stroke, aortic valve stenosis, kidney failure, pancreatitis, allergy, anemia, atherosclerosis, a metabolic disease, a cardiovascular disease, a chemotherapy/radiation related complication, diabetes type I, diabetes type II, a liver disease, a gastrointestinal disorder, an ophthalmological disease, allergic conjunctivitis, diabetic retinopathy, Sjogren's syndrome, uveitis, a pulmonary disorder, a renal disease, HIV-related cachexia, cerebral malaria, ankylosing spondylitis, lupus, dermatitis, leprosy, fibromyalgia, contact dermatitis, eczema, dry eye disease and Behcet's disease in a human or animal, the compound having a structure which is selected from: and or an anhydride, solvate or pharmaceutically acceptable salt thereof. 
Spoj za uporabu u liječenju ili sprječavanju bolesti izabrane između psorijaze, atopijskog dermatitisa, psorijaznog artritisa, reumatoidnog artritisa, upalne bolesti crijeva, multiple skleroze, neurodegerativnog poremećaja, kongestivne srčane insuficijencije, moždanog udara, stenoze zaliska aorte, zatajenja bubrega, pankreatitisa, alergije, anemije, ateroskleroze, bolesti metabolizma, kardiovaskularne bolesti, komplikacije povezane s kemoterapijom/zračenjem, dijabetesa tipa I, dijabetesa tipa II, bolesti jetre, gastrointestinalnog poremećaja, oftalmološke bolesti, alergijskog konjuktivitisa, dijabetičke retinopatije, Sjogren-ovog sindroma, uveitisa, plućnog poremećaja, bolesti bubrega, kaheksije povezana s HIV-om, cerebralne malarije, ankilozantnog spondilitisa, lupusa, dermatitisa, lepre, fibromijalgije, kontaktnog dermatitisa, ekcema, bolest suhih očiju i Behcet-ove bolesti kod ljudi ili životinja, naznačeno time da spoj ima strukturu koja je izabrana između:
A formulation for use according to claims 4 to 15 which further comprises an additional pharmaceutical agent, e.g. 
Formulacija za uporabu prema zahtjevima 4 do 15 koja nadalje sadrži dodatni farmaceutski agens, npr.
The oligonucleotide decoy of claim 8, further comprising a third transcription factor binding site, wherein said third transcription factor binding site binds to a transcription factor selected from the group consisting of POU1F1, POU2F, POU3F, POU5F1, USF, EGR1, CREB/ATF, AP1, CEBP, SRF, ETS1, MEF2, SP1, RUNX, NFAT, ELK1, ternary complex factors, STAT, GATA1, ELF1, nuclear factor-granulocyte/macrophage a, POU4F1, HNF1, ZFHX3, IRF, TEAD1, TBP, NFY, caccc-box binding factors, KLF4, KLF5, KLF7, IKZF, MAF, REST, HSF, KCNIP3 and PPAR transcription factors. 
Oligonukleotidna zamka prema zahtjevima 1 do 3, naznačena time, da nadalje obuhvaća treće mjesto spajanja faktora transkripcije, pri čemu se navedeno treće mjesto spajanja faktora transkripcije, spaja na faktor transkripcije odabran iz skupine faktora transkripcije koju čine: POU1F1, POU2RF, POU3F, POU5F1, USF, EGR1, CREB/ATF, AP1, CEBP, SRF, ETS1, MEF2, SP1, RUNX, NFAT, ELK1, ternalni kompleksni faktori, STAT, GATA1, ELF1, nuklearni faktor-granulocita/makrofaga, POU4F1, HNF1, ZFHX3, IRF, TEAD1, TBP, NFY, faktori spajanja caccc-box-a, KLF4, KLF7, IKZF, MAF, REST, HSF, KCNIP3 i PPAR.
A pharmaceutical composition comprising an oligonucleotide decoy of claim 1 and a pharmaceutically acceptable carrier. 
Farmaceutski sastav, naznačen time, da obuhvaća oligonukleotidnu zamku prema bilo kojem od zahtjeva 1 do 4 i farmaceutski prihvatljiv nosač.
an enhanced anabolic activity. 
poboljšana anabolička aktivnost.
A combination according to claim 11, wherein the pain is selected from peripheral neuropathic pain, allodynia, causalgia, hyperalgesia, hyperesthesia, hyperpathia, neuralgia, neuritis and neuropathy. 
Kombinacija prema zahtjevu 11, naznačena time da je bol odabrana od periferne neuropatske boli, alodinije, kauzalgije, hiperalgezije, hiperestezije, hiperpatije, neuralgije, neuritisa i neuropatije.
A compound according to claims 13 or 14, wherein the pain is selected from peripheral neuropathic pain, allodynia, causalgia, hyperalgesia, hyperesthesia, hyperpathia, neuralgia, neuritis and neuropathy. 
Spoj prema zahtjevima 13 ili 14, naznačen time da je bol odabrana od periferne neuropatske boli, alodinije, kauzalgije, hiperalgezije, hiperestezije, hiperpatije, neuralgije, neuritisa i neuropatije.